Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,599 | 3,685 | 5,165 | 3,082 | 4,443 |
| Other current assets | 13 | 13 | 23 | 101 | 0 |
| TOTAL | $9,815 | $3,968 | $5,464 | $3,353 | $4,749 |
| Non-Current Assets | |||||
| PPE Net | 1,643 | 1,529 | 1,534 | 1,394 | 1,477 |
| Other Non-Current Assets | 76 | 102 | 121 | 143 | 178 |
| TOTAL | $1,719 | $1,631 | $1,656 | $1,537 | $1,655 |
| Total Assets | $11,534 | $5,599 | $7,119 | $4,890 | $6,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 674 | 220 | 214 | 161 | 109 |
| Accrued Expenses | 1,369 | 1,097 | 805 | 888 | 832 |
| TOTAL | $2,117 | $1,414 | $1,119 | $1,149 | $1,041 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2 | 4 | 25 | 49 | 72 |
| TOTAL | $2 | $4 | $25 | $49 | $72 |
| Total Liabilities | $2,119 | $1,417 | $1,144 | $1,198 | $1,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,468 | 1,035 | 972 | 454 | 374 |
| Retained earnings | -45,761 | -43,437 | -41,517 | -40,088 | -38,490 |
| TOTAL | $9,415 | $4,181 | $5,975 | $3,693 | $5,290 |
| Total Liabilities And Equity | $11,534 | $5,599 | $7,119 | $4,890 | $6,403 |